Low dose and quantitative total body PET/CT for preclinical imaging
In this webinar, Dr. Ali Asgar Attarwala, Nuclear Molecular Imaging Scientist at Bruker Biospin and a Medical Physicist by qualification, will give insights into the effects of ionising radiation on study animals and how the resultant biological effect can influence the integrity of the research outcomes. In effect, he will present a new preclinical PET/CT system with design features which make it suitable for small animal low-dose imaging. The CT subsystem uses an X-Ray source power that is optimized for small animal imaging and a PET subsystem with a sensitivity of 9% (NEMA) that can be leveraged for use of low tracer doses and performing rapid scans. This combination has enabled total-body mouse PET/CT studies to be completed with absorbed doses of below 10 mGy.
The webinar would appeal to oncologists, biologists, radiochemists, medical physicists, clinicians, radiation technologists and drug developers involved in diagnostic imaging in both clinical and preclinical settings.
Ionising Radiation Effects in preclinical Imaging
Low dose imaging
The recorded version will be sent to all registrants shortly after the live sessions. Don’t miss it!
You have been sent this email as a valuable contact of Bruker BioSpin. We at Bruker take data protection seriously. Click here to view our updated Privacy & Cookies Policy. Bruker complies with the new General Data Protection Regulation (GDPR). We are committed to keeping our customers informed and would like to share news with you. If you feel at any time that your needs have changed and you no longer wish to receive these news, then you can unsubscribe from these communications click here to opt out.
Bruker Corporation | 15 Fortune Drive | MA 01821 Billerica | Massachusetts | United States